Serum Institute of India (SII) has announced its partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) network, based in Oslo. This collaboration aims to facilitate the swift development and supply of outbreak vaccines, particularly for Disease X or unknown pathogenic threats, in Global South countries. CEPI is investing up to $30 million to enhance SII's capacity for rapid vaccine supply during epidemics and pandemics.
